Literature DB >> 8238254

Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma.

C Sundberg1, M Ljungström, G Lindmark, B Gerdin, K Rubin.   

Abstract

The expression of platelet-derived growth factor- beta (PDGF-beta) receptors in the microvasculature of human healing wounds and colorectal adenocarcinoma was investigated. Frozen sections were subjected to double immunofluorescence staining using monoclonal antibodies (MAbs) specific for pericytes (MAb 225.28 recognizing the high-molecular weight-melanoma-associated antigen, expressed by activated pericytes during angiogenesis), endothelial cells (MAb PAL-E), laminin, as well as PDGF-beta receptors (MAb PDGFR-B2) and its ligand PDGF-B chain (MAb PDGF 007). Stained sections were analyzed by computer-aided imaging processing that allowed for a numerical quantification of the degree of colocalization of the investigated antigens. An apparent background colocalization, varying between 23 and 35%, between markers for cells not expected to co-localize was recorded. This background could be due to limitations of camera resolution, to out-of-focus fluorescence, and to interdigitations of the investigated structures. In all six tumor specimens, co-localization of PDGF-beta receptors and PAL-E was not different from the background co-localization, whereas that of PDGF-beta receptors and high-molecular weight-melanoma-associated antigen was significantly higher with mean values between 57 and 71%. Qualitatively, the same pattern was obtained in the two investigated healing wounds. PDGF-B chain did not co-localize with either PAL-E or high-molecular weight-melanoma-associated antigen, but PDGF-B chain-expressing cells were, however, frequently found juxtaposed to the microvasculature. The expression of PDGF-beta receptors on pericytes in activated microvessels and the presence of PDGF-B chain-expressing cells in close proximity to the microvasculature of healing wounds and colorectal adenocarcinoma is compatible with a role for PDGF in the physiology of the microvasculature in these conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238254      PMCID: PMC1887183     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors.

Authors:  L T Furcht
Journal:  Lab Invest       Date:  1986-11       Impact factor: 5.662

Review 2.  The pericyte--a review.

Authors:  D E Sims
Journal:  Tissue Cell       Date:  1986       Impact factor: 2.466

Review 3.  The biology of platelet-derived growth factor.

Authors:  R Ross; E W Raines; D F Bowen-Pope
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

4.  Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation.

Authors:  K Rubin; L Terracio; L Rönnstrand; C H Heldin; L Klareskog
Journal:  Scand J Immunol       Date:  1988-03       Impact factor: 3.487

5.  Two classes of PDGF receptor recognize different isoforms of PDGF.

Authors:  C E Hart; J W Forstrom; J D Kelly; R A Seifert; R A Smith; R Ross; M J Murray; D F Bowen-Pope
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

6.  Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.

Authors:  M R Ziai; L Imberti; M R Nicotra; G Badaracco; O Segatto; P G Natali; S Ferrone
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

7.  Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components.

Authors:  A Orlidge; P A D'Amore
Journal:  Microvasc Res       Date:  1986-01       Impact factor: 3.514

8.  A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets.

Authors:  M Nistér; A Hammacher; K Mellström; A Siegbahn; L Rönnstrand; B Westermark; C H Heldin
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

9.  Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.

Authors:  K Rubin; A Tingström; G K Hansson; E Larsson; L Rönnstrand; L Klareskog; L Claesson-Welsh; C H Heldin; B Fellström; L Terracio
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

10.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.

Authors:  A Orlidge; P A D'Amore
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  35 in total

1.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells.

Authors:  C Sundberg; M Branting; B Gerdin; K Rubin
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

Review 4.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

5.  Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.

Authors:  E S Yi; H Lee; S Yin; P Piguet; I Sarosi; S Kaufmann; J Tarpley; N S Wang; T R Ulich
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

6.  Platelet-derived growth factor BB induces functional vascular anastomoses in vivo.

Authors:  D M Brown; S P Hong; C L Farrell; G F Pierce; R K Khouri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.

Authors:  Bing Xie; Jikui Shen; Aling Dong; Mara Swaim; Sean F Hackett; Lorenza Wyder; Susanne Worpenberg; Samuel Barbieri; Peter A Campochiaro
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

8.  Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.

Authors:  Toshio Kuwai; Toru Nakamura; Sun-Jin Kim; Takamitsu Sasaki; Yasuhiko Kitadai; Robert R Langley; Dominic Fan; Stanley R Hamilton; Isaiah J Fidler
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 9.  Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.

Authors:  Benjamin D Humphreys
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

10.  Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate.

Authors:  Joan Manel Gasent Blesa; Enrique Grande Pulido; Juan Laforga Canales; Vicente Alberola Candel
Journal:  Case Rep Oncol       Date:  2009-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.